tert-Butyl rel-((1R,2S)-2-carbamoylcyclopentyl)carbamate

Catalog No. :
ACTGID376
CAS No. :
494209-36-8
Molecular Formula :
C11H20N2O3
Molecular Weight :
228.29

IUPAC Name:tert-butyl ((1R,2S)-2-carbamoylcyclopentyl)carbamate

tert-Butyl rel-((1R,2S)-2-carbamoylcyclopentyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$114.00Login to see priceInquiryInquiry
250mg97%$176.00Login to see priceInquiryInquiry
1g97%$431.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl rel-((1R,2S)-2-carbamoylcyclopentyl)carbamate
IUPAC Nametert-butyl ((1R,2S)-2-carbamoylcyclopentyl)carbamate
Molecular FormulaC11H20N2O3
Molecular Weight228.29
SMILESCC(C)(C)OC(=O)N[C@@H]1CCC[C@@H]1C(N)=O
InChI KeyIPZHOKFZGXCJJP-JGVFFNPUSA-N
SynonymCis-tert-butyl-2-carbamoylcyclopentylcarbamate;Carbamic acid, N-[(1R,2S)-2-(aminocarbonyl)cyclopentyl]-, 1,1-dimethylethyl ester, rel-;tert-Butyl rel-((1R,2S)-2-carbamoylcyclopentyl)carbamate;tert-butyl ((1R,2S)-2-carbamoylcyclopentyl)carbamate
CAS No.494209-36-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACTGID376 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBJRF136 route compound structure diagram
    ACBJRF136137170-89-9 In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACTGID376 route product structure diagram
    ACTGID376494209-36-8
Inquiry

2. ACTGID376 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTGID376 route product structure diagram
    ACTGID376494209-36-8
Inquiry

Comments (0)